rs432946

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000153.4(GALC):​c.*626C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.466 in 1,496,608 control chromosomes in the GnomAD database, including 166,121 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.49 ( 19129 hom., cov: 34)
Exomes 𝑓: 0.46 ( 146992 hom. )

Consequence

GALC
NM_000153.4 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 1.12

Publications

9 publications found
Variant links:
Genes affected
GALC (HGNC:4115): (galactosylceramidase) This gene encodes a lysosomal protein which hydrolyzes the galactose ester bonds of galactosylceramide, galactosylsphingosine, lactosylceramide, and monogalactosyldiglyceride. Mutations in this gene have been associated with Krabbe disease, also known as globoid cell leukodystrophy. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Jul 2008]
GALC Gene-Disease associations (from GenCC):
  • Krabbe disease
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, PanelApp Australia, Genomics England PanelApp, Laboratory for Molecular Medicine, Myriad Women’s Health, Labcorp Genetics (formerly Invitae), ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 14-87934106-G-A is Benign according to our data. Variant chr14-87934106-G-A is described in ClinVar as Benign. ClinVar VariationId is 314739.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.597 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000153.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GALC
NM_000153.4
MANE Select
c.*626C>T
3_prime_UTR
Exon 17 of 17NP_000144.2P54803-1
GALC
NM_001201401.2
c.*626C>T
3_prime_UTR
Exon 16 of 16NP_001188330.1P54803-3
GALC
NM_001201402.2
c.*626C>T
3_prime_UTR
Exon 17 of 17NP_001188331.1P54803-4

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GALC
ENST00000261304.7
TSL:1 MANE Select
c.*626C>T
3_prime_UTR
Exon 17 of 17ENSP00000261304.2P54803-1
GALC
ENST00000921945.1
c.*626C>T
3_prime_UTR
Exon 16 of 16ENSP00000592004.1
GALC
ENST00000950382.1
c.*626C>T
3_prime_UTR
Exon 17 of 17ENSP00000620441.1

Frequencies

GnomAD3 genomes
AF:
0.493
AC:
74806
AN:
151854
Hom.:
19099
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.603
Gnomad AMI
AF:
0.500
Gnomad AMR
AF:
0.397
Gnomad ASJ
AF:
0.490
Gnomad EAS
AF:
0.187
Gnomad SAS
AF:
0.423
Gnomad FIN
AF:
0.479
Gnomad MID
AF:
0.459
Gnomad NFE
AF:
0.478
Gnomad OTH
AF:
0.487
GnomAD4 exome
AF:
0.463
AC:
622699
AN:
1344636
Hom.:
146992
Cov.:
24
AF XY:
0.462
AC XY:
305847
AN XY:
661946
show subpopulations
African (AFR)
AF:
0.609
AC:
18519
AN:
30418
American (AMR)
AF:
0.328
AC:
11117
AN:
33874
Ashkenazi Jewish (ASJ)
AF:
0.473
AC:
11016
AN:
23272
East Asian (EAS)
AF:
0.198
AC:
7021
AN:
35488
South Asian (SAS)
AF:
0.409
AC:
30426
AN:
74430
European-Finnish (FIN)
AF:
0.459
AC:
14795
AN:
32264
Middle Eastern (MID)
AF:
0.433
AC:
2174
AN:
5022
European-Non Finnish (NFE)
AF:
0.477
AC:
502185
AN:
1053714
Other (OTH)
AF:
0.453
AC:
25446
AN:
56154
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
15120
30240
45360
60480
75600
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
15224
30448
45672
60896
76120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.493
AC:
74889
AN:
151972
Hom.:
19129
Cov.:
34
AF XY:
0.488
AC XY:
36245
AN XY:
74250
show subpopulations
African (AFR)
AF:
0.603
AC:
24992
AN:
41450
American (AMR)
AF:
0.396
AC:
6044
AN:
15246
Ashkenazi Jewish (ASJ)
AF:
0.490
AC:
1703
AN:
3472
East Asian (EAS)
AF:
0.187
AC:
965
AN:
5156
South Asian (SAS)
AF:
0.424
AC:
2047
AN:
4826
European-Finnish (FIN)
AF:
0.479
AC:
5054
AN:
10548
Middle Eastern (MID)
AF:
0.463
AC:
136
AN:
294
European-Non Finnish (NFE)
AF:
0.478
AC:
32457
AN:
67960
Other (OTH)
AF:
0.491
AC:
1036
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1933
3866
5799
7732
9665
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
660
1320
1980
2640
3300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.498
Hom.:
4693
Bravo
AF:
0.489
Asia WGS
AF:
0.398
AC:
1382
AN:
3478

ClinVar

ClinVar submissions as Germline
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Galactosylceramide beta-galactosidase deficiency (1)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
8.3
DANN
Benign
0.47
PhyloP100
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs432946; hg19: chr14-88400450; API